M. Majem , V. Gregorc , G. Lo Russo , M. Maio , S. Salvagni , V. Gutierrez Calderon , M. Gonzalez Cao , S. Sandiego Contreras , A. Koumarianou , A. Bearz , R. Bernabe Caro , S. Viteri , M.F. Sanmamed , F. Zagouri , M.T. Moran Bueno , Y. Zhang , Y. Shan , H. Zhu , R. Rosell
{"title":"LBA1:一线(1L) fulzerasib + cetuximab治疗KRAS G12Cm晚期NSCLC:来自KROCUS研究的最新疗效和安全性","authors":"M. Majem , V. Gregorc , G. Lo Russo , M. Maio , S. Salvagni , V. Gutierrez Calderon , M. Gonzalez Cao , S. Sandiego Contreras , A. Koumarianou , A. Bearz , R. Bernabe Caro , S. Viteri , M.F. Sanmamed , F. Zagouri , M.T. Moran Bueno , Y. Zhang , Y. Shan , H. Zhu , R. Rosell","doi":"10.1016/S1556-0864(25)00194-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S1"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study\",\"authors\":\"M. Majem , V. Gregorc , G. Lo Russo , M. Maio , S. Salvagni , V. Gutierrez Calderon , M. Gonzalez Cao , S. Sandiego Contreras , A. Koumarianou , A. Bearz , R. Bernabe Caro , S. Viteri , M.F. Sanmamed , F. Zagouri , M.T. Moran Bueno , Y. Zhang , Y. Shan , H. Zhu , R. Rosell\",\"doi\":\"10.1016/S1556-0864(25)00194-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Page S1\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425001947\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425001947","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.